Clinical impact of insulin resistance on pulmonary vein isolation outcome in patients with paroxysmal atrial fibrillation.


Journal

Journal of cardiovascular electrophysiology
ISSN: 1540-8167
Titre abrégé: J Cardiovasc Electrophysiol
Pays: United States
ID NLM: 9010756

Informations de publication

Date de publication:
04 2019
Historique:
received: 23 10 2018
revised: 10 12 2018
accepted: 18 12 2018
pubmed: 24 12 2018
medline: 21 7 2020
entrez: 22 12 2018
Statut: ppublish

Résumé

The relationship between insulin resistance and atrial fibrillation (AF) recurrence after pulmonary vein isolation (PVI) remains unclear. Drug-refractory 114 paroxysmal AF patients (89 males, 62 ± 8 years) who underwent successful PVI were enrolled. Homeostasis model assessment of insulin resistance (HOMA-IR) was calculated and a value of ≥2.5 was defined as insulin resistant. The left atrial volume index (LAVI) was measured using echocardiography before and 1 year after PVI. Tumor necrosis factor-α (TNF-α) and TGF-β1 serum levels were measured before PVI, and the left atrium (LA) conduction velocity was calculated. The patients were divided into two groups (group 1: HOMA-IR < 2.5, n = 81; group 2: HOMA-IR ≥ 2.5, n = 33). The LAVI between the two groups before PVI did not significantly differ (P > 0.05), nor did TNF-α (7.7 ± 2.0 vs 7.5 ± 1.0 pg/mL; P = 0.149) or TGF-β1 (28.4 ± 12.0 vs 27.6 ± 10.3 ng/mL; P = 0.757). LAVI before and 1 year after PVI in each group did not change. The conduction velocity of group 2 was slower than that of group 1 (0.7 ± 0.1 vs 1.1 ± 0.3 m/s, P < 0.001). Kaplan-Meier analysis showed significantly higher AF recurrence in group 2 than that in group 1 ( P = 0.019). Cox multivariable analysis revealed that insulin resistance was an independent predictor of recurrence (hazard ratio 1.287, P = 0.004). Our results suggest that insulin resistance promotes LA electrical remodeling and might be related to AF recurrence after PVI.

Identifiants

pubmed: 30575179
doi: 10.1111/jce.13827
doi:

Substances chimiques

Biomarkers 0
Blood Glucose 0
Insulin 0

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

479-486

Informations de copyright

© 2018 Wiley Periodicals, Inc.

Auteurs

Naoko Hijioka (N)

Department of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.

Masashi Kamioka (M)

Department of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.

Yoshiyuki Matsumoto (Y)

Department of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.

Minoru Nodera (M)

Department of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.

Shinya Yamada (S)

Department of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.

Takashi Kaneshiro (T)

Department of Arrhythmia and Cardiac Pacing, Fukushima Medical University, Fukushima, Japan.

Akiomi Yoshihisa (A)

Department of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.

Takafumi Ishida (T)

Department of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.

Yasuchika Takeishi (Y)

Department of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH